These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3882004)

  • 1. Reduction of distress in hyperprolactinemia with bromocriptine.
    Buckman MT; Kellner R
    Am J Psychiatry; 1985 Feb; 142(2):242-4. PubMed ID: 3882004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bromocriptine on affect and libido in hyperprolactinemia.
    Koppelman MC; Parry BL; Hamilton JA; Alagna SW; Loriaux DL
    Am J Psychiatry; 1987 Aug; 144(8):1037-41. PubMed ID: 3300375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin, aggression and hostility: a discussion of recent studies.
    Kellner R; Buckman MT; Fava M; Fava GA; Mastrogiacomo I
    Psychiatr Dev; 1984; 2(2):131-8. PubMed ID: 6483849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine improves reduced libido and potency in men receiving maintenance hemodialysis.
    Muir JW; Besser GM; Edwards CR; Rees LH; Cattell WR; Ackrill P; Baker LR
    Clin Nephrol; 1983 Dec; 20(6):308-14. PubMed ID: 6357576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borderline hyperprolactinemia in infertile women: evaluation of the prolactin response to thyrotropin releasing hormone and double-blind placebo-controlled treatment with bromocriptine.
    Glazener CM; Kelly NJ; Hull MG
    Gynecol Endocrinol; 1987 Dec; 1(4):373-8. PubMed ID: 3140587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No effect of bromocriptine in acromegaly: a controlled trial.
    Lindholm J; Riishede J; Vestergaard S; Hummer L; Faber O; Hagen C
    N Engl J Med; 1981 Jun; 304(24):1450-4. PubMed ID: 7015129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovary syndrome.
    Buvat J; Buvat-Herbaut M; Marcolin G; Racadot A; Fourlinnie JC; Beuscart R; Fossati P
    J Clin Endocrinol Metab; 1986 Jul; 63(1):119-24. PubMed ID: 3519644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine for treatment of benign breast disease. A double-blind clinical trial versus placebo.
    Parlati E; Polinari U; Salvi G; Giorlandino C; Liberale I; Fiorella G; Dell'Acqua S
    Acta Obstet Gynecol Scand; 1987; 66(6):483-8. PubMed ID: 3321867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine treatment of spasmodic torticollis. A double-blind crossover study.
    Juntunen J; Kaste M; Iivanainen M; Ranta T; Seppälä M
    Arch Neurol; 1979 Jul; 36(7):449-50. PubMed ID: 378199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved sexual function in male haemodialysis patients on bromocriptine.
    Bommer J; Ritz E; del Pozo E; Bommer G
    Lancet; 1979 Sep; 2(8141):496-7. PubMed ID: 90217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromocriptine in the treatment of hypertension.
    Walden RJ; Hernandez J; Bhattacharjee P; Graham B; Prichard BN
    Eur J Clin Pharmacol; 1986; 30(2):141-4. PubMed ID: 3519242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease.
    Mansel RE; Preece PE; Hughes LE
    Br J Surg; 1978 Oct; 65(10):724-7. PubMed ID: 361149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.
    Webster J; Piscitelli G; Polli A; Ferrari CI; Ismail I; Scanlon MF
    N Engl J Med; 1994 Oct; 331(14):904-9. PubMed ID: 7915824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome.
    Walters AS; Hening WA; Kavey N; Chokroverty S; Gidro-Frank S
    Ann Neurol; 1988 Sep; 24(3):455-8. PubMed ID: 3067654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosomatic aspects of hyperprolactinemia.
    Fava M; Fava GA; Kellner R; Buckman MT; Lisansky J; Serafini E; DeBesi L; Mastrogiacomo I
    Psychother Psychosom; 1983; 40(1-4):257-62. PubMed ID: 6657880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: eight-week randomized, single-blind, placebo-controlled, multicenter study.
    Lee MS; Song HC; An H; Yang J; Ko YH; Jung IK; Joe SH
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):19-27. PubMed ID: 19968833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin-lowering effect of acute and once weekly repetitive oral administration of cabergoline at two dose levels in hyperprolactinemic patients.
    Mattei AM; Ferrari C; Baroldi P; Cavioni V; Paracchi A; Galparoli C; Romano C; Spellecchia D; Gerevini G; Crosignani PG
    J Clin Endocrinol Metab; 1988 Jan; 66(1):193-8. PubMed ID: 3275684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperprolactinemia in oligospermic Nigerian males: effect of bromocriptine treatment.
    Modebe O
    Int J Fertil Menopausal Stud; 1994; 39(2):95-9. PubMed ID: 8012447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromocriptine and premenstrual tension: a clinical and hormonal study.
    Andersch B; Hahn L
    Pharmatherapeutica; 1982; 3(2):107-13. PubMed ID: 7201645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of bromocriptine in unexplained primary infertility: a double-blind controlled trial.
    Wright CS; Steele SJ; Jacobs HS
    Br Med J; 1979 Apr; 1(6170):1037-9. PubMed ID: 376036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.